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Abstract
Tools from molecular biology, in combination with in vivo optical imaging techniques, provide 
new mechanisms to noninvasively observe brain processing. Current approaches primarily probe 
cell-based variables, such as cytosolic calcium or membrane potential, but not cell-to-cell 
signaling. Here we introduce CNiFERs, cell-based neurotransmitter fluorescent engineered 
reporters, to address this challenge and monitor in situ neurotransmitter receptor activation. 
CNiFERs are cultured cells that are engineered to express a chosen metabotropic receptor, make 
use of the Gq protein-coupled receptor cascade to transform receptor activity into a rise in 
cytosolic [Ca2+], and report [Ca2+] with a genetically encoded fluorescent Ca2+ sensor. The initial 
realization of CNiFERs detects acetylcholine release via activation of M1 muscarinic receptors. 
Chronic implantation of M1-CNiFERs in frontal cortex of the adult rat is used to elucidate the 
muscarinic action of the atypical neuroleptics clozapine and olanzapine. We show that these drugs 
potently inhibit in situ muscarinic receptor activity.
A central tenet of neuronal processing is that unidirectional cell-to-cell communication is 
based on the release and subsequent binding of cell signaling molecules. Signaling can be 
localized to a pair of cells, as occurs with transmission across a synaptic cleft. Signaling can 
also occur within a volume of tissue through the diffusion of molecules away from the 
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cleft1, 2. The spillover of glutamate, the excitatory transmitter among central synapses, leads 
to glutamatergic activation of extrasynaptic metabotropic receptors on nearby neurons and 
glia. Central modulators, including acetylcholine, serotonin, norepinephrine, and numerous 
neuropeptides, are commonly released directly into the extracellular space and have long-
lasting and long-range effects on central processing. The dual nature of signaling, synaptic 
versus volume, suggests the possibility of different design strategies for functional probes of 
these two forms of communications.
The molecular detection of neuronal signaling molecules has achieved success for the case 
of glutamate through the fusion of pairs of fluorescent proteins with bacterial periplasmic 
proteins that bind small molecules3-5. Binding of glutamate leads to a structural change in 
the protein and a subsequent change in fluorescence resonance energy transfer (FRET) 
between the fluorescent proteins. Conceptually similar work involved the fusion of specific 
G-protein receptors with pairs of fluorescent proteins6. Such functionalized proteins are 
suitable for the detection of both synaptic and volume transmission. However, each 
molecular detector must be engineered de novo and used in combination with a suitable 
expression vector. We sought an alternate, modular approach for the detection of neuronal 
signaling molecules, with a focus on volume signaling.
Results
Our design exploits the modularity of G-protein receptors and their downstream pathways to 
expand on concepts from three past technological developments. First, cultured Xenopus 
myocytes that expressed nicotinic acetylcholine receptors have been used as in vitro 
electrophysiological reporters of pulsatile acetylcholine (Ach) release7. This work inspired 
the development of a cancerous cell line that expressed purinergic receptors for use as a 
detector of adenosine triphosphate release8. Second, high-throughput drug screening 
technologies can image receptor-transfected cells which are loaded with functional 
fluorescent dyes9. Third, implanted cultured cells filled with organic calcium indicators have 
been used as a test bed for fiber-optic imaging in rat cortex10. We express G-protein coupled 
receptors, whose inventory includes affinity for virtually every known signaling molecule, 
together with genetically expressible indicators of second messengers to create implantable 
cellular sensors of receptor activity.
This first realization of CNiFERs addresses the detection of acetylcholine (Ach) released 
into the extracellular space11. This central modulator plays a prominent role in attention, 
learning and cortical plasticity12 and is thought to influence the etiology of schizophrenia13. 
M1-CNiFERs are engineered from HEK293 cells that stably express the M1 receptor, a 
major muscarinic receptor in neocortex14, and the fusion-protein and calcium indicator TN-
XXL15 (Fig. 1a). Activation of the M1 receptor increases cytosolic calcium in M1-CNiFERs 
via the Gq/IP3 second messenger pathway. The subsequent binding of Ca2+ to TN-XXL 
induces a conformational change that enhances FRET between its cyan and yellow 
fluorescent protein domains15. Thus M1-CNiFERs report M1 receptor activity by a 
concurrent decrease in cyan and increase in yellow fluorescence. Lastly, control-CNiFERs 
express TN-XXL but not the M1 receptor; they are distinguished by expression of mCherry 
fluorescent protein (Fig. 1a).
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The FRET response of M1-CNiFERs is studied under two-photon laser scanning 
microscopy16 (TPLSM); we report the change in FRET as
where background values are subtracted from the individual fluorescent channels and the 
prestimulus period is typically 10 s. Bath application of an 500 s bolus of acetylcholine (1 to 
1000 nM) reveals two time-scales of the M1-CNiFER response. An initial phasic response, 
with an EC10 of 3 nM and an EC50 of 11 nM, is followed by a plateau response with an 
EC10 of 5 nM and an EC50 of 9 nM (Fig. 1b,c). These values compare well with the 1 to 100 
nM acetylcholine levels measured in rat brain with microdialysis17, 18. Lastly, the phasic 
response is independent of external calcium concentration while the tonic response is 
abolished in calcium-free media (Sup. Fig. 1).
The phasic response was further probed with a fast perfusion system using 2.5 s applications 
of 60 or 100 nM acetylcholine, for which the peak responses are ΔF/F = 0.3 and 0.9, 
respectively (Fig. 1d). M1-CNiFERs respond within 2 s with a half-maximal rise-time of ~ 2 
s, a full width at half maximal amplitude of ~ 7 s and can resolve pulses of 100 nM 
acetycholine with an interstimulus interval as short as 6 s (Fig. 1e). Adaptation of the second 
response can be seen for the interstimulus interval of 21 s (Fig. 1e); further investigation 
reveals that the peak M1-CNiFER FRET response to pulses of acetylcholine adapts with a 
time constant of roughly 102 s towards an asymptotic value (Sup. Fig. 2). Lastly, we tested 
if M1-CNiFERs respond to a slowly increasing ramp in [ACh] that, in principle, could be 
undetected if adaptation is strong. For a concentration close to EC50 reached over 103 s, 
sensitivity was maintained (Sup. Fig. 3).
The specificity of M1-CNiFERs was a concern since HEK293 cells can express endogenous 
surface receptors. We thus screened for potentially confounding receptor activation on a 
high-throughput fluorometric plate reader; the atropine sensitive response of M1-CNIFERs 
to a saturating level of acetylcholine ([ACh] = 100 nM) served as a reference (Sup. Fig. 4) 
and we report  and 
. First, the activation of control-CNiFERs by 
acetylcholine is negligile, i.e.,  (Fig. 1f,g). Potentially confounding 
neurotransmitters typically have EC50 > 1–10 μM and  (Fig. 1g). 
Notable exceptions include norepinephrine , adenosine 
, and vasoactive intestinal peptide  (Fig. 1f,g).
M1- and control-CNiFERs are implanted in discrete sites in frontal cortex of rat and imaged 
by TPLSM down to 300 μm below the cortical surface (Fig. 2). The typical imaging plane 
contains contributions from 10 to 30 CNiFERs per site. We test if implanted M1-CNiFERs 
are still functional by puffing acetylcholine from a pipette inserted near the implantation 
site. Volume injection of 5 to 50 nl of 1 mM acetylcholine, but not vehicle, elicit large 
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FRET responses in M1-CNiFERs (Sup. Fig. 5). To test that short, physiologically relevant 
bursts of endogenous acetylcholine will diffuse into the CNiFER sites at detectable 
concentrations, we electrically stimulate nucleus basalis magnocellularis (NBM), a basal 
forebrain structure that projects cholinergic fibers into neocortex. Single-train excitation of 
NBM induces a transient shift in the spectral content of the electrocorticogram that lowers 
the amplitude of the 1 to 6 Hz δ-band rhythms for several seconds (Fig. 2b); this pattern is a 
hallmark of NBM stimulation19, 20. Concomitantly, M1-CNiFERs respond with a single 
peak initiated within 2 s, a half-maximal rise time of ~ 1 s and a width of less than 10 s; 
simultaneously imaged control-CNiFERS do not respond (Fig. 2b). This temporal resolution 
is comparable to that of electrochemistry and ~ 100 times faster than microdialysis. Lastly, 
we observe a strong correlation between electrocorticogram activation, measured as the Z-
score of minus the logarithm of the power in the δ-band of the ECoG for a given animal, and 
response amplitude in M1, but not control, CNiFERs (n = 4 animals, 55 trials) (Fig. 2c), ang 
anticipated result19.
The cholinergic nature of the in vivo M1-CNiFER response is verified by subcutaneous 
injection of physostigmine, an acetylcholinesterase inhibitor, that enhances the amplitude 
and duration of the NBM-evoked M1-CNiFER response for ~ 5000 s after injection (n = 3) 
(Fig. 2d). The ability of M1-CNiFERs to detect slow fluctuations in endogenous 
acetylcholine in the absence of NBM stimulation was tested by administering a relatively 
high dose of physostigmine to enhance the basal concentration of acetylcholine. We observe 
a concomitant enhancement in the M1- but not control-CNiFER FRET (n = 3) (Fig. 2e) that 
is accompanied by a reduction of power in the δ-band of the ECoG. Collectively, these acute 
experiments (Fig. 2) support the use of CNiFERs to detect small changes in the 
physiological release of acetylcholine.
Chronically implanted M1-CNiFERs can be imaged for at least six days (Fig. 3a). Imaging 
in the X-Z plane shows that the M1-CNiFER response to NBM stimulation extends 
throughout the depth of the implantation (Fig. 3a). The time dependence of the response is 
very similar to that found with acutely implanted M1-CNiFERs and, further, control-
CNiFERs remain non-responsive (11 of 12 rats) (Fig. 3b). Images of intravenous fluorescein 
reveal patent vasculature around the implantations (Sup. Fig. 6) and immunohistochemistry 
demonstrates minimal tissue damage, negligible presence of reactive astrocytes, and no 
evidence for intracortical cell proliferation (Sup. Fig. 7). As confirmation that M1-CNiFERs 
respond to muscarinic activation, we observe that reverse dialysis of 1 to 5 μM atropine near 
the site of implantation acts to reduce the NBM-evoked M1-CNiFER response in a 
reversible manner (n = 3) (Fig. 3c); a dose of 100 μM atropine essentially abolishes the 
response (n = 3) (Fig. 3c). Pairs of NBM stimuli are resolvable by M1-CNiFERs with an 
interstimulus interval greater than 5 s (Fig. 3d), consistent with in vitro experiments (Fig. 
1e). Finally, the response from chronically recorded M1-CNiFERs is monotonic with 
increasing stimulation intensity and duration (Fig. 3e,f), consistent with increased NBM 
recruitment and augmentation of acetylcholine release within cortex.
As a test bed for M1-CNiFERs, we address the action of a class of antipsychotic drugs, 
called atypical neuroleptics21, on cholinergic transmission. Atypical neuroleptics, the 
overwhelming preference for managing schizophrenia22, are primarily anti-dopaminergic 
Nguyen et al. Page 4
Nat Neurosci. Author manuscript; available in PMC 2014 April 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
compounds with a broad spectrum of activity at other receptors. Many atypicals have 
marked cholinergic effects that are believed to contribute to their improved therapeutic 
properties23. The atypicals olanzapine and clozapine elicit substantial acetylcholine release 
peripherally24 and centrally25, 26, though they are also muscarinic (Sup. Fig. 4)27, 28 and 
nicotinic antagonists24. Furthermore, a bioactive metabolite of clozapine, n-
desmethylclozapine, acts as a muscarinic receptor agonist29. The net effect of atypicals on 
muscarinic transmission is debated30. On the one hand, enhanced cholinergic release might 
explain the effectiveness of atypicals in improving cognition in schizophrenics29, 31. On the 
other hand, antagonism of the muscarinic receptor can account for their favorable profile of 
extrapyramidal side effects23. We use M1-CNiFERs to resolve these mutually exclusive 
alternatives.
We find that the atypical neuroleptic olanzapine profoundly depresses the M1-CNiFER 
FRET response to periodic stimulation of NBM. In contrast, essentially no change in the 
FRET response is seen after the injection of vehicle (Fig. 4a). The M1-CNiFER response in 
the presence of olanzapine is partially recovered by an increase in the amplitude of the NBM 
stimulation (Fig. 4a, red lines), suggestive of competitive inhibition. The suppressive effects 
of olanzapine on M1 receptor activation, as well as that of a second atypical neuroleptic, 
clozapine, is seen across a cohort of animals (n = 4 each) (Fig. 4b,c). Clozapine also 
suppresses NBM-evoked electrocorticogram activation, consistent with a blocking effect on 
endogenous M1 receptors in vivo (Sup. Fig. 8, olanzapine not tested). Further, suppression 
of M1-CNiFER activation by olanzapine is not dependent on repetitive stimulation, as 
olanzapine depresses the NBM-evoked response when NBM is first stimulated 1000 s after 
the injection of olanzapine (Sup. Fig. 9). As a final control, we find that the conventional 
antipsychoticsy chlorpromazine and haloperidol have no observable effect on the NBM-
evoked M1-CNiFER response (n = 3 - 4 each) (Fig. 4d,e).
To test for olanzapine's net effect on extrasynaptic muscarinic transmission, as modeled by 
the response of chronically implanted M1-CNiFERs, we injected olanzapine at a dose 
known to increase cortical acetylcholine levels 6-fold26. We find a negligible and 
statistically insignificant M1- as well as control-CNiFER FRET response (Fig. 4f,g). In 
contrast, nicotine ditartrate, which raises cortical acetylcholine levels 3-fold32, leads to a 
significant increase in the response of M1- but not control-CNiFERs (Fig. 4f,g). 
Collectively, the results with M1-CNiFERs indicate the atypical neuroleptics clozapine and 
olanzapine, unlike conventional antipsychotics, are potent in vivo inhibitors of extrasynaptic 
M1 muscarinic receptors as expressed in M1-CNiFERS implanted in frontal cortex. This 
occurs in spite of their marked ability to stimulate central acetylcholine release25, 26. Our 
findings account for the reduced extrapyramidal side effects associated with atypical 
antipsychotic drugs, as these side effects and antimuscarinic activity are inversely related33. 
They do not support the contention that clozapine and olanzapine activate extrasynaptic 
cortical M1 receptors indirectly via acetylcholine release.
Discussion
The response of CNiFERs will adapt upon exposure to a constant concentration of agonist. 
This appears as a phasic response that decays to a persistent, tonic level over ~ 102 s (Figs. 
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1b,c, and 4a). The phasic component does not depend on the external [Ca2+] (Sup. Fig. 1) 
and is consistent with a Ca2+ flux that derives from the endoplasmic reticulum as part of 
inositol triphosphate (IP3) receptor-activation in the Gq-protein cascade34. The transition 
from the larger amplitude of the phasic response to the smaller tonic response can result 
from a decrement in signaling molecule binding at any point in the muscarinic Gq-protein 
cascade. Past work implies that there is little desensitization or internalization of the M1 
receptor35. In contrast, [Ca2+] mirrors [IP3] and IP3 exhibits both phasic and tonic 
components36, similar to the components seen with CNiFERs (Fig. 1b). Thus a rate-limiting 
step in the generation of IP3, such as the availability of the intermediate phosphatidylinositol 
4,5-bisphosphate37, may explain the adaptation of the CNiFERs. A complementary 
explanation for the adaptation is that the tonic response is maintained via calcium flux 
through the cytoplasmic membrane rather than internal calcium stores, as evidenced by the 
abolishment of the tonic signal in calcium free media (Sup. Fig. 1).
CNiFERs indirectly report neurotransmitter release but directly report receptor sub-type 
activity, a measurement not possible using microdialysis, electrochemistry, or radioisotope 
tracers. They provide a general approach to observe the activation of G protein-coupled 
receptors by small molecules and peptides within living animals. CNiFERS for Gq protein-
coupled receptors, such as those for the molecular transmitters serotonin and prostaglandins, 
can be engineered as an immediate extension of the M1-CNiFERs and their Ca2+-based 
response. In contrast, CNiFERS for Gs and Gi/o protein-coupled receptors, such as those for 
the peptide transmitters vasoactive intestinal peptide and somatostatin, respectively, can be 
based on changes in the concentration of cAMP detected via a genetically encoded indicator 
for the activation of protein kinase A38. Alternatively, an endogenous indicator for Ca2+ can 
be used if co-expressed with the promiscuous Gα1639 or Gα chimeras40; these G proteins 
allow receptors not normally linked with the Gq pathway to elicit cytosolic Ca2+. Thus 
future CNiFERs may be realized to detect any signaling molecule, of which 
neurotransmitters are a broad and important class, that activates a G protein-coupled 
receptor.
Methods
Stably expressing cell lines
CNiFERs were created through replication deficient lentiviral transduction of HEK293 cells 
with cDNAs of the TN-XXL calcium indicator15, human M1 muscarinic receptor (gift from 
Paul Slesinger, Salk Institute), and mCherry fluorescent protein41 (gift from Roger Y. Tsien, 
UCSD). M1- and control-CNiFERs both express TN-XXL but are differentiated by either 
M1 receptor or mCherry expression, respectively. cDNAs were subcloned into HIV-based 
backbone cloning plasmids (System Biosciences, Mountain View, CA). Lentiviral particles 
were produced by the UCSD Vector Development Laboratory. Serial dilution clonal 
selection was assisted by puromycin (M1) and fluorescence (TN-XXL and mCherry). 
CNiFER clones were selected based on response to acetylcholine and fluorescence 
intensities. Clones were divided into aliquots and frozen with 10 % dimethyl sulfoxide at T 
= − 80°C. CNiFERs were maintained at 37°C and 10 % CO2 using Fisher Scientific 10 and 
Forma Scientific 3546 incubators (Thermo Scientific, MA). Upon confluence 
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(approximately twice weekly), cells were trypsinized, triturated, and seeded into new, 500 
ml flasks with 0.2 μm filtered caps, using Dulbecco's Modification of Eagle's Medium 
(Cellgro®; Mediatech, Inc, VA) with addition of Glutamax™-1 (Invitrogen, CA) and 10 % 
(v/v) of Fetalplex™ serum (Gemini Bio-Products, CA). New aliquots of CNiFERs were 
thawed every 30 to 50 passages.
TPLSM imaging
CNiFERs were imaged with a custom two-photon laser scanning fluorescence microscope42 
that runs the MPScope software suite43. A femtosecond laser (Verdi oscillator with Mira 
pump laser, Coherent, Mountain View, CA) provided excitation light either at 760 nm to 
visualize mCherry, taking advantage of the anomalous excitation of mCherry at λ < 780 
nm44, or at 800 nm to excite the eCFP portion of TN-XXL while largely avoiding Citrine 
cp174. Fluorescence signals, collected either by 20X or 40X water dipping objectives (UIS2, 
Olympus, Center Valley, PA), were split into three channels: 455 to 495 nm (eCFP), 515 to 
545 nm (eCFP and Citrine) and > 580 nm (mCherry). XY-image sizes were 256 by 256 or 
512 by 512 pixels taken at 2 to 3 frames per second. XZ-imaging was achieved in line scan 
mode by moving the focal plane with a MIPOS 100 piezoelectric z-axis lens positioner 
(Piezosystem Jena, Jena, Germany) synchronized with the line scan. XZ-frames sizes were 
256 by 256 pixels taken at 2 frames per second.
In vitro TPLSM testing
M1- and control-CNiFERs were plated on fibronectin-coatedcoverslips, placed in a cell 
culture chamber (RC26; Warner Instruments, CT) and perfused withartificial cerebral spinal 
fluid (ACSF: 125 mM NaCl, 5 mM KCl, 10 mM D-glucose, 10 mMHEPES, 3.1 mM CaCl2, 
1.3 mM MgCl2, pH 7.4). Chamber fluid temperature was kept at 32°C bya temperature 
controller (TC-324B; Warner Instruments, CT). Rapid acetylcholine presentationwas 
achieved with an actuated perfusion stepper (SF-77B; Warner Instruments, CT). 
Theacetylcholine pipette was occasionally co-loaded with Alexa-594 to determine actual 
perfusiontimes. Bath acetylcholine presentation was delivered via gravity-feed.
In vitro high-throughput testing
FRET responses of M1- and control-CNiFERs to various ligands were measured in vitro 
using a high-throughput fluorometric plate reader (FlexStation® 3, Molecular Devices, 
Sunnyvale, CA). The day before experiments, M1- or control-CNiFERs were seeded in 
poly-D-lysine coated 96-well plates at 0.12×106 cells per well. Media was replaced in each 
well with 100 μl ACSF and plates were loaded into the FlexStation® 3. Experiments were 
conducted at 37°C using 435 nm excitation. Emitted light was collected at 485 nm and 527 
nm every 3.8 s and ligand was delivered in 50 μl boluses without trituration. Background 
signals measured from neighboring wells without cells were subtracted, fluorescence 
intensities were normalized to pre-stimulus baselines, and peak responses selected from the 
ratio of the 527 nm and 485 nm channels. All peaks were then normalized by the M1-
CNiFER response to maximal acetylcholine.
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In vivo surgery and electrode placement
Adult male Sprague-Dawley rats (250-600 gm) were anesthetized with isoflurane according 
to standard protocol45 and implanted with epidural 125 μm Teflon-coated silver-chloride 
wires across the imaging site for differential electrocorticogram (ECoG) recordings (A-M 
Systems Inc., WA). In each nucleus basalis magnocellularis (NBM) stimulation experiment, 
two 0.1 MΩ tungsten stimulating electrodes (Microprobes Inc., MD) spaced ~ 0.5 mm apart 
were implanted at the coordinates (2.1 mm, −1.2 mm, −6.9 mm)20. Electrical stimulation 
consisted of 200 μs current-pulses of 100 to 1000 μA, at 100 Hz, for a duration of 20 to 500 
ms. The depth of implantation and magnitude of current was adjusted to a value that would 
produce cortical activation, as assayed by reductions in cortical large-amplitude electrical 
oscillations46; this value was typically 200 μA.
In vivo implantation
CNiFERs were triturated from culture flasks without trypsin, concentrated, and resuspended 
in ACSF for injection. After a craniotomy over frontal or parietal cortex and dural resection, 
CNiFERs were loaded into a ~ 40 μm inner-diameter glass pipette connected to a syringe 
pump and stereotaxically injected ~ 500 μm from the cortical surface using a syringe pump. 
Flow was stopped immediately after cells were seen to move down the pipette shaft, and 
pipette removal delayed for 5 min to prevent backflow of cells. In an attempt to avoid 
damage to the parenchyma this is far less than previous injection of transformed fibroblasts 
in ex vivo gene therapy experiments, which approximated 105 cells in 3 μl of media47. After 
implantation in several adjacent sites, usually 4 to 5 sites for M1-CNiFERs and 2 to 3 for 
control-CNiFERs, the craniotomy was filled with 1.5 % agarose in ACSF and sealed with a 
coverslip using dental cement48. Acute and chronic implantations were similar, except that 
in the latter, rats were immune-suppressed by daily cyclosporine injection (Belford 
Laboratories; 20 μl/100 gm, i.p.) starting one day before implantation. For acetylcholine 
puffing experiments an opening into the craniotomy was preserved to allow pipette 
insertion.
In vivo imaging
All in vivo imaging was performed under urethane (1.3-1.5 g/kg i.p.). For acetylcholine 
puffing, capillary pipettes with ~ 25 μm inner diameter were filled with PBS or 1 mM 
acetylcholine chloride in PBS and affixed to an oocyte injector (Nanoject II, Drummond, 
PA). The capillary tip was maneuvered into the window using a micromanipulator (MP-285; 
Sutter, CA) and positioned near the CNiFER implants. Experimental runs consisted of 10 s 
baselines followed by 5 to 50 nl injections. For NBM electrical stimulation experiments, 200 
μs pulses of 100-1000 μA, at 20 Hz or 100 Hz, were delivered for a duration of 5 s or 20 to 
500 ms, respectively. Electrocorticogram signals were amplified with a DAM80 differential 
amplifier (World Precision Instruments, CT), using a bandpass of 0.1 to 100 Hz, and gain of 
1000. Cerebrovasculature was visualized by injecting 500 μl of 5 % (w/v) fluorescein 
dextran (Sigma; I.V.).
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In vivo pharmacology
For acetylcholinesterase inhibition experiments, subcutaneous physostigmine salicylate in 
100 mM phosphate-buffered saline was injected at 200 or 300 μg/kg. Intracerebral atropine 
perfusion was performed by a syringe pump connected to a microdialysis probe (CMA 11; 
CMA, North Chelmsford, MA) implanted 1000 μm into cortex and ~2 mm from CNiFERs. 
Flow rate was set to 2 to 15 μl/min. Neuroleptics were dissolved in vehicle using 1 % (v/v) 
glacial acetic acid in PBS and a total volume of 1 ml/kg was injected intraperitoneally. 
Atypical neuroleptics were used at dosages similar to those in other studies designed to 
match human therapeutic plasma drug levels30, 49. Nicotine ditartrate was used for nicotine 
experiments and delivered in a volume of 1 ml/kg intraperitoneally. Drugs were purchased 
from Sigma or A.G. Scientific.
Data analysis
All TN-XXL fluorescence intensities were background-subtracted and normalized to pre-
stimulus baselines, as noted in the equation in the text, as ΔR/R. In vitro, images were 
averaged to include all cells in the field of view. In vivo, regions of interest were drawn 
around either M1- or control-CNiFER implants generally encompassing 10 to 150 cells.
For ECoG time-series epochs, spectral power densities were estimated using the multi-taper 
algorithm in Chronux Analysis Software for Matlab (http://chronux.org). Post-stimulus 
time-series consisted of a single 5 s epoch beginning 600 ms after NBM stimulus onset. 
Baseline epochs consisted of four, 5 s epochs immediately preceding NBM stimulus onset. 
We chose a time-bandwidth product of 5 for 9 tapers. The measure of δ-band ECoG activity 
was found by: (1) calculating the spectral power of each time series, where the time series 
for the n-th trial is denoted Vn(t) and the corresponding spectral power is denoted ; (2) 
calculating the power in the 1 to 6 Hz δ-band as ; (3) taking the 
logarithm of , which is χ2-distributed, to form the Gaussian distributed variable 
; where the minus sign reflects the decrease in power with increasing 
activation; (4) Z-score equalizing the log-power as 
 to permit comparisons between animals.
Smoothed lines for CNiFER responses made with the Bayesian adaptive regression splines 
nonparametric smoothing algorithm for normally distributed data (Figs. 1b and 2d,e)50 
(http://www.stat.cmu.edu/~jliebner/).
Histological Procedure Adult animals were perfused with phosphate buffered saline (PBS) 
for the generation of fresh tissue. The typical perfusion volumes were 0.5 ml per gram 
animal and flow rates were 20 ml/min. The PBS perfusion was immediately followed by a 
second perfusion with 4 % (w/v) paraformaldehyde (PFA) in PBS. The extracted brain was 
stored in 4 % PFA in PBS for post-fixation. Blocking of the tissue, if necessary, was done 
with a mounted razor blade. α-GFAP rabbit antibodies (Zymed, CA) were used to visualize 
astrocytes. Sections were quenched in 3% hydrogen peroxide for 15 minutes then incubated 
overnight in a 1:200 dilution of primary α-GFAP antibody in the diluent used throughout the 
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histological process: PBS containing 0.25% Triton, 5% goat serum and 0.02% sodium azide. 
After washing for 1 hour, α-GFAP sections were incubated in a 1:500 dilution of 
biotinylated α-rabbit secondary antibody (Vector Laboratories, CA). This was followed by 
the avidin:biotinylated complex method (Vectastain ABC kit, Vector Laboratories, CA) and 
3,3'-diaminobenzidine (DAB) visualization with nickel. Sections were mounted on slides 
and imaged on an upright microscope with brightfield for DAB stains and epifluorescence 
for M1- and control-CNiFERs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Design and in vitro characterization of CNiFERs
(a) CNiFERs used in this study are HEK293 cells that stably express the M1 muscarinic 
receptor and the FRET-based calcium indicator TN-XXL (M1-CNiFERs), or TN-XXL and 
mCherry (control-CNiFERs) (Methods in Supplemental Material). In M1-CNiFERs, 
acetylcholine is depicted as activating M1 to induce IP3-mediated Ca2+ cytoplasmic influx 
detected by TN-XXL. Fluorescence from the eCFP (cyan) and Citrine cp174 (yellow) 
fluorescent proteins incorporated into TN-XXL are collected for the FRET-based signal. (b) 
M1-CNiFERs respond to an 500 s bath application of acetylcholine with two time-scales: a 
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phasic response that peaks within ~ 20-40 s and a tonic plateau that stabilizes after ~ 300 s. 
(c) M1-CNiFER phasic response to acetylcholine is monotonic in the range 1 – 100 nM, 
with an EC50 of 11 nM, a Hill coefficient of 1.9, and a maximum of ΔR/R = 1.1. The tonic 
response is monotonic in the range 5-30 nM, with an EC50 of 9 nM, a Hill coefficient of 4.4 
and a maximum of ΔR/R = 0.18. Phasic responses are measured as the maximum value of 
ΔR/R between 0 and 100 s after lowpass filtering of the data at 0.3 Hz, while tonic responses 
are measured as the average value of ΔR/R between 300 and 400 s (n = 3). (d) Acetylcholine 
presentation of ~2.5 s (red trace) to M1-CNiFERs leads to opposing responses in cyan (475 
nm) versus yellow (530 nm) fluorescence. The response initiates within 2 s with a full-width 
half maximal response of ~ 7 s (n = 5). (e) Two M1-CNiFER FRET-based responses to 100 
nM acetylcholine can be discriminated with an interstimulus interval of 6 s or longer (n = 3). 
(f) Dose-response of M1-CNiFERs (cyan) and control-CNiFERs (red) to a subset of 
endogenous neurotransmitters: acetylcholine (ACh), vasoactive intestinal peptide (VIP), 
norepinephrine (NE), and dopamine (DA) (n = 5). (g) Summary of screening data at 
physiologically relevant concentrations reveals that M1-CNiFERs respond with greatest 
amplitude to acetylcholine, while control-CNiFERs are non-responsive to acetylcholine (n = 
3 – 5). All bars are standard errors.
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Figure 2. In vivo characterization of acutely implanted M1-CNiFERs
(a) Stimulating electrodes are implanted in NBM to recruit the cortical afferent cholinergic 
system, and electrocorticogram wires are placed to detect NBM-evoked cortical activation 
(Methods in Supplemental Material). M1-CNiFERs and control-CNiFERs are implanted in 
separate columns in neocortex, where cholinergic terminals are widely distributed, and 
imaged acutely or chronically using two-photon laser scanning microscopy. To the right, a 
two-photon microscopy image of M1-CNiFERs (cyan) and control-CNiFERs (red) 
implanted in rat motor cortex in 25 – 50 μm diameter columns. Data represent a Z-projection 
from 40 – 60 μm below the cortical surface. There are ~ 10 – 20 CNiFER cells per site in 
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this field of view. (b) M1-CNiFER FRET responses (lower) and ECoG activity (upper) 
evoked by increasing levels of NBM electrical stimulation. Cortical activation appears as a 
shift from large to small amplitude waves. Control-CNiFERs are non-responsive. (c) M1-
CNiFER response to NBM stimulation is strongly correlated to loss of power in the 
electrocorticogram δ-band, quantified as the Z-score normalized logarithm of the reciprocal 
of the power, -log[power in ECoG δ-band], for each animal (Methods; Supplemental 
Material). CNiFER responses are defined as the area under the curve of ΔR/R for 10 s after 
the stimulus normalized to that of 10 s before the stimulus (n = 55 trials with 4 animals). (d) 
Subcutaneous physostigmine salicylate at 200 μg/kg enhances the amplitude and duration of 
M1-CNiFER response to NBM stimulation. The response disappears by ~ 8000 s. Data in 
bottom trace represent the fractional change of 1/3 the area under the curve of ΔR/R for 30 
seconds after the stimulus as compared to that of 10 s before the stimulus. Top traces are 
examples of raw data used to calculate bottom trace; NBM stimulation occurs every 300 s 
and vehicle in PBS (n = 3). (e) Subcutaneous physostigmine salicylate at 300 μg/kg causes 
an increase in baseline M1-CNiFER FRET fluorescence over ~ 8000 s. This appears to 
result from modulation of background levels of acetylcholine in cortex. M1-CNiFERs 
(cyan) and control-CNiFERs (red) measured as an average over 10 s every 300 s (top). All 
measurements are normalized to first 3 measurements before vehicle injection, and not to 
internal baselines, thus preserving the tonic response. Data from 4 consecutive 300 s epochs 
for each animal (n = 4), and plotted in black at each time point (bottom). All bars are 
standard errors.
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Figure 3. Chronic implantation of CNiFERs
(a) Chronically implanted M1- and control-CNiFER sites are shown on the left, a X-Z time 
series from the M1-CNiFERs in response to a single-train NBM stimulation is shown in the 
center and the average intensity (mean ± standard error; n = 4 animals) of the M1-CNiFER 
response as a function of depth is shown on the right. (b) Electrocorticogram and FRET 
responses in M1- and control-CNiFERs in response to NBM stimulation; 300 ms train of 
300 μA pulses (Methods; Supplemental Material). (c) Atropine antagonism. Left traces: M1-
CNiFER responses to single-train NBM stimulation are inhibited by reverse dialysis of 
intracortical atropine sulfate. Bar graph: average peak inhibition of CNiFER response due to 
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1 – 5 μM atropine (23 ± 4 %) (n = 4 rats) or 100 μM atropine (87 ± 16 %) (n = 3 rats). (d) 
Temporal resolution of acutely implanted M1-CNiFERs. Top pane: stimulation protocol. 
Traces: Each trace represents the mean response of M1-CNiFERs to two consecutive 
stimulations of NBM (n = 5 for each condition, repeated over 3 animals). (e) Response of 
M1-CNiFERs versus stimulation current. Top pane: stimulation protocol. Graph: average 
M1-CNiFER response normalized to that at 500 μA (n = 6 rats). (f) Response versus 
duration of the stimulation train. Top pane: stimulation protocol. Graph: average M1-
CNiFER response normalized to that at 500 ms (n = 6 rats). The black curves in (e) and (f) 
are visual aids.
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Figure 4. In vivo pharmacology of chronically implanted M1-CNiFERs
(a) Olanzapine intraperitoneal injection at 3 mg/kg suppresses the M1-CNiFER response 
elicited by repetitive NBM stimulation (500 μA; black vertical dashed lines). The M1-
CNiFER response is partially recovered by increasing the amplitude of NBM stimulation (1 
mA; red vertical dashed lines). (b-e) Atypical, but not conventional, antipsychotics suppress 
the M1-CNiFER response elicited by NBM stimulation. Graphs: M1-CNiFER peak response 
normalized to those averaged during vehicle injection; olanzapine at 3-5 mg/kg (n = 4); 
clozapine at 5 mg/kg (n = 4); chlorpromazine at 5 mg/kg (n = 4); and haloperidol at 1 mg/kg 
(n = 3). Grey: vehicle. Black: antipsychotic. (f) Olanzapine, injected i.p. at a dose of 10 
mg/ml, does not elicit a response in M1-CNiFERs while nicotine ditartrate (green), injected 
i.p. at a dose of 1 mg/ml elicits a response. (g) Composite results (n = 4 rats) of the 
maximum response, measured between 120 and 720 s after injection. The response of M1-
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CNiFERs to nicotine is significantly greater than that for controls, while the response of M1-
CNiFERS to olanzapine is at chance. **Significantly different values by t-test (p < 0.05).
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